Intestinal bacterial metabolite of naturally occurring 20(S)-protopanaxatrial Ginsenosides is the inhibitor of CYP3A--a new biotransformation way with potential for clinical drug-drug interaction (第26回 生体膜と薬物の相互作用シンポジウム 講演要旨集)

スポンサーリンク

概要

• 論文の詳細を見る
• 日本薬学会の論文
• 2004-11-25

著者

• Yang Sheng-li

  Laboratory Of Pharmaceutical Resource Discovery Dalian Institute Of Chemical Physics Chinese Academy

• Yang Sheng-li

  中華人民共和国

• Liu Yong

  Laboratory Of Pharmaceutical Resource Discovery Dalian Institute Of Chemical Physics Chinese Academy

• Liu Y

  Dalian Inst. Chemical Physics Chinese Acad. Sci. Dalian Chn

• Yang Ling

  Laboratory Of Pharmaceutical Resource Discovery Dalian Institute Of Chemical Physics Chinese Academy

• Liu Yong

  Laboratory Of Pharmaceutical Resource Discovery Dalian Institute Of Chemical Physics Chinese Academy

関連論文

• A Dammarane Glycoside Derived from Ginsenoside Rb_3
• The Inhibitory Effect of Intestinal Bacterial Metabolite of Ginsenosides on CYP3A Activity(Pharmacology)
• Expression of Adenovirus Type 5 E1A in the Methylotrophic Yeast Pachia pastoris and the Inhibitory Effect on S-180 Tumor Growth
• Intestinal bacterial metabolite of naturally occurring 20(S)-protopanaxatrial Ginsenosides is the inhibitor of CYP3A--a new biotransformation way with potential for clinical drug-drug interaction (第26回 生体膜と薬物の相互作用シンポジウム 講演要旨集)
• Structure Elucidation of Major Metabolites from Medroxyprogesterone Acetate by P450
• Acceptor Specificity and Transfer Efficiency of a β-Glycosidase from the China White Jade Snail
• Determination of UDP-glucuronosyltransferase UGT2B7 activity in human liver microsomes by ultra-performance liquid chromatography with MS detection

スポンサーリンク